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third question relates to the pharmacological therapy in patients
who developed spinal cord ischemia. There is literature to support
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The kind of wait-and-see approach advocated in the accompanying
article1 works best if corrective measures can be initiated within
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Dr Peter H. Lin (Houston, Tex). The authors from the
University of Alabama should be congratulated on an excellent
study regarding the use of lumbar spinal drainage following tho-
racic endograft placement. Considering the presenting author is a
second-year medical student as well as an aspiring future vascular
surgeon, he should also be congratulated on a well-presented
study. In this report, the authors described their institutional
protocol regarding selective usage of lumbar drain in patients who
developed postoperative spinal cord ischemia following thoracic
aortic endograft placement. The authors reported several risk
factors which were associated with increased post-TEVAR spinal
cord ischemia, which included prior infrarenal aortic pathology,
length of thoracic aortic endograft coverage, and history of stroke.
I have three questions for the authors. First, given the study
findings which showed risk factors such as prior infrarenal aortic
pathology, long length of thoracic aortic endograft coverage, and
history of stroke were associated with increased spinal cord isch-
emia, have these findings changed your treatment approach when
encountering patients with these risk factors? Would you recom-
mend routine or prophylactic spinal drainage prior to thoracic
endograft placement in these patients, or would you advocate
selective spinal drain as mentioned in your protocol? My second
question is a clinical scenario. Considering the study finding which
showed patients with prior infrarenal aortic pathology who un-
dergo thoracic endovascular repair have higher risk of spinal cord
ischemia, what would be your treatment approach when encoun-
tering a patient with concomitant infrarenal aortic aneurysm and
thoracic aortic aneurysm in which both aneurysms have similar
size? Would you recommend staged endovascular treatment? If so,
which one would you approach first? Or would you perform a
combined endovascular treatment with spinal drain placement?Myhe use of steroids in these patients as a means to reduce swelling
nd spinal cord edema. Your study protocol did not include the use
f steroids in patients who develop spinal cord ischemia. Can you
hare your thoughts as to why this was not included in your
harmacological treatment protocol in patients with spinal cord
schemia?
Once again, the authors should be congratulated on an excel-
ent study. I thank the authors for providingme with a well-written
anuscript in a timely fashion and I also thank the association for
he privilege of discussing this paper.
Dr Charles J. Keith, Jr. Thank you, Dr Lin, for your com-
ents and questions. First, I would like to address your question
bout the prophylactic drainage. The use of prophylactic drainage
as been advocated in some studies and literature; however, if we
ad deployed prophylactic lumbar drain in all patients with infra-
enal pathology we would have deployed an additional and unnec-
ssary 105 drains. These drains would have required increased
onitoring, an increased length of stay, and increased cost. You
lso cannot neglect the certain risks that come along with drainage,
n particular an epidural hematoma, as was experienced by one of
ur patients. Secondly, in regards to your clinical scenario about
eparate abdominal and thoracic aneurysms, clinical decisions
ould be based on themerits of each aneurysm separately based on
ize thresholds and anatomic constraints. Certainly, we would
refer a staged approach if appropriate with choice of which
neurysm to approach first based on weighing several of these
actors, reserving selective lumbar drainage for those that develop
eurologic symptoms. Finally, I would like to address your ques-
ion about the role of steroids. We did not include steroids in our
rotocol. Our neurosurgeons who had input into developing and
arrying out this protocol do not support steroid use, but in some
ettings it may be something to consider.INVITED COMMENTARYTimothy A. M. Chuter, MD, San Francisco, Calif
Although endovascular techniques avoid some intraoperative
causes of spinal ischemia, such as aortic cross-clamp and hemody-
namic instability, thoracic aortic exclusion inevitably occludes all
the intercostal arteries within the field of the repair, leaving seg-
ments of the spine dependent on collateral flow. The resulting
lower extremity weakness tends to be delayed, partial, and revers-
ible.Many large studies have shown routine spinal fluid drainage to
be a highly effective preventative measure following open surgical
repair of the thoracoabdominal1 and descending thoracic segments
of the aorta. The same appears to be true of endovascular repair.2-5
The metabolic effects of neuronal ischemia contribute to a
positive feedback loop that soon makes the process irreversible.inutes of symptom onset. A mean delay of 8 hours between
ymptom onset and cerebrospinal fluid drainage may explain why
nly 3/10 patients regained full lower extremity motor function.
n even longer delay of 19 hours in the three patients with
bsolutely no resolution of symptoms probably contributed to
heir poor outcome. Tomakematters worse, all seven patients with
esidual lower extremity weakness were dead within a year.
Routine spinal fluid drainage largely eliminates treatment
elays and has proven to be an effective means of preventing
araplegia.3 The benefits of this prophylactic measure vary with the
isk of paraplegia. The overall rate (6%) of lower extremity weak-
ess reported in the accompanying article is fairly typical and one
ight argue, as the authors do, that routine spinal drainage of
very patient undergoing endovascular thoracic aortic repair is
1JOURNAL OF VASCULAR SURGERY
Volume 55, Number 1 Chuter 9unwarranted. However, some patients are at far more risk of
paraplegia than others. Higher rates are seen in the presence of
renal impairment,4,5 extensive repair,2,6-10 abdominal aortic aneu-
rysm,6,7 subclavian artery occlusion,2,8-10 internal iliac artery oc-
clusion,2 and hypotension.2,9 A truly selective approach triages
high-risk patients to routine drainage and low-risk patients to
elective (often much delayed) drainage.
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